Pigs as models of human cancers

Tatiana Flisikowska1, Alexander Kind1, Angelika Schnieke1

  • 1Chair of Livestock Biotechnology, Scholl of Life Sciences Weihenstephan, Technische Universität München, Freising, Germany.

Theriogenology
|May 10, 2016
PubMed

Insights

Genetically engineered pigs offer a more human-relevant model for cancer research, bridging the gap between lab discoveries and clinical applications for new cancer treatments.

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Significant advancements in understanding cancer's molecular mechanisms.
  • Need to translate laboratory findings into clinical oncology for patient benefit.
  • Limitations of current animal models, like mice, for preclinical studies.

Purpose of the Study:

  • To review genetically modified porcine cancer models.
  • Highlight the potential of pigs as physiologically relevant models for cancer research.
  • Discuss the application of these models in developing and validating new cancer therapies.

Main Methods:

  • Review of scientific literature on genetically modified porcine cancer models.
  • Analysis of the suitability of pigs for preclinical cancer studies.
  • Exploration of genetic engineering techniques applied to pigs for cancer modeling.

Main Results:

  • Genetic engineering methods are now applicable to pigs, enabling the creation of large-scale, genetically defined cancer models.
  • Pigs offer a more physiologically relevant alternative to traditional animal models for cancer research.
  • These porcine models hold promise for improving the preclinical evaluation of cancer medicines and procedures.

Conclusions:

  • Genetically modified pigs represent a significant advancement in preclinical cancer research.
  • Porcine cancer models can facilitate the translation of molecular discoveries into clinical applications.
  • Further development and utilization of these models are crucial for advancing cancer treatment strategies.